| CAS: | 103577-45-3 | ||||||||
| 分子式: | C16H14F3N3O2S | ||||||||
| 分子量: | 369.36 | ||||||||
| 中文名称: |
| ||||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| L797762 | MACKLIN | 兰索拉唑 | 10mM in DMSO | 449元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| L0233 | TCI | Lansoprazole | >98.0%(T)(HPLC) | 760元/1G; 2035元/5G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 952517 | J&K | Lansoprazole | 98%, 一种质子泵抑制剂(PPI) | 862元/1G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Lansoprazole是一种质子泵抑制剂(PPI),防止胃产生胃酸。 靶点(IC50 & Targe) Proton pump [1] 体外研究 Lansoprazole通过抑制胃氢/钾的腺苷三磷酸酶抑制胃酸分泌(H +,K + - ATP酶),胃壁细胞膜的酶形成所述质子泵,是酸分泌过程中的最后步骤的一部分的酶。Lansoprazole共价结合于壁细胞的H +,K + - ATP酶,使其无功能和抑制胃酸的分泌。[1] Lansoprazole是一种很强的抗分泌剂,作用于胃H +/ K+ - 腺苷胃壁细胞三磷酸的(H+/ K+ ATP酶)。Lansoprazole抑制血管粘附分子的表达增加,中性粒细胞的活化,以及生产促炎细胞因子从激活的内皮细胞的产生。Lansoprazole诱导的几个基因,包括在胃上皮细胞中的II期解毒酶(NADPH-泛醌氧化还原酶,谷胱甘肽S-转移酶)和抗氧化应激蛋白(HO-1,硫氧还蛋白还原酶,和超氧化物歧化酶)的表达。Lansoprazole显著抑制IL-1β刺激的RGM-1细胞中生产CINC-1。在大鼠胃上皮细胞中,Lansoprazole上调HO-1表达,并且有抗炎作用。[2] 体内研究 在大鼠中,Lansoprazole抑制ischemia-reperfusion或indomethacin 诱导的急性炎性反应,以及肠粘膜损伤。Lansoprazole显著抑制ischemia-reperfusion或indomethacin 诱发的肠损伤。Lansoprazol外源施用防止小肠中ischemia-reperfusion或indomethacin 诱导的损伤。[2] 参考文献 [1] Garnett WR, et al. Ann Pharmacother, 1996, 30(12), 1425-1436. [2] Takagi T, et al. J Clin Biochem Nutr, 2009, 45(1), 9-13. 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR1390 | Supelco | Lansoprazole | Pharmaceutical Secondary Standard; Certified Reference Material | 1359.83元/1 G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Lansoprazole is an important proton pump inhibitor and a substituted benzimidazole with antisecretory and antiulcer activities. Its mode of action involves the suppression of gastric acid secretion by specific inhibition of the gastric H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cells. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. 分析说明 These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC3483 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| L8533 | Sigma-Aldrich | Lansoprazole | ≥98% (TLC), powder | 676.58元/250 MG; 2158.12元/1 G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 生化/生理作用 胃质子泵抑制剂。 特点和优势 该化合物由 Novartis 开发。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单,请单击此处。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000773 | Lansoprazole | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 60 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000774 | Lansoprazole for peak identification | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 1.01 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BP872 | Lansoprazole | British Pharmacopoeia (BP) Reference Standard | 1861.35元/100 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1356916 | USP | Lansoprazole | United States Pharmacopeia (USP) Reference Standard | 3231.47元/150 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BP873 | Lansoprazole impurity standard | British Pharmacopoeia (BP) Reference Standard | 1916.08元/25 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||